Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hough

Showing results (361-370 of 404) with videos related to

Pageof 41
Sort By:
Thorax|October 15, 2025
Greater recovery after critical illness (GRACE): a call to action to create a new roadmap for critical illness researchDylan Flaws, Jonathan D Stewart, Kimberley Joy Haines, et al.
The Lancet. Respiratory Medicine|May 3, 2024
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trialMatthew F Mart, Leanne M Boehm, Amy L Kiehl, et al.
Annals of the American Thoracic Society|June 4, 2020
Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19Jonathan D Casey, Nicholas J Johnson, Matthew W Semler, et al.
Critical Care Medicine|November 14, 2018
Models of Peer Support to Remediate Post-Intensive Care Syndrome: A Report Developed by the Society of Critical Care Medicine Thrive International Peer Support CollaborativeJoanne McPeake, Eliotte L Hirshberg, Leeann M Christie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial VirusKevin C Ma, Diya Surie, Yuwei Zhu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Pageof 41

Showing results (361-370 of 404) with videos related to

Sort By:
Pageof 41
Thorax|October 15, 2025
Greater recovery after critical illness (GRACE): a call to action to create a new roadmap for critical illness researchDylan Flaws, Jonathan D Stewart, Kimberley Joy Haines, et al.
The Lancet. Respiratory Medicine|May 3, 2024
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trialMatthew F Mart, Leanne M Boehm, Amy L Kiehl, et al.
Annals of the American Thoracic Society|June 4, 2020
Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19Jonathan D Casey, Nicholas J Johnson, Matthew W Semler, et al.
Critical Care Medicine|November 14, 2018
Models of Peer Support to Remediate Post-Intensive Care Syndrome: A Report Developed by the Society of Critical Care Medicine Thrive International Peer Support CollaborativeJoanne McPeake, Eliotte L Hirshberg, Leeann M Christie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial VirusKevin C Ma, Diya Surie, Yuwei Zhu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Pageof 41